AU3735000A - Modulation of substance p by gaba analogs and methods relating thereto - Google Patents
Modulation of substance p by gaba analogs and methods relating theretoInfo
- Publication number
- AU3735000A AU3735000A AU37350/00A AU3735000A AU3735000A AU 3735000 A AU3735000 A AU 3735000A AU 37350/00 A AU37350/00 A AU 37350/00A AU 3735000 A AU3735000 A AU 3735000A AU 3735000 A AU3735000 A AU 3735000A
- Authority
- AU
- Australia
- Prior art keywords
- modulation
- substance
- methods relating
- gaba analogs
- gaba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13261499P | 1999-05-05 | 1999-05-05 | |
US60132614 | 1999-05-05 | ||
PCT/US2000/006199 WO2000067742A2 (en) | 1999-05-05 | 2000-03-10 | Use of gaba analogues for the modulation of substance p |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3735000A true AU3735000A (en) | 2000-11-21 |
Family
ID=22454836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU37350/00A Abandoned AU3735000A (en) | 1999-05-05 | 2000-03-10 | Modulation of substance p by gaba analogs and methods relating thereto |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3735000A (en) |
WO (1) | WO2000067742A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1202725E (en) * | 1999-07-22 | 2007-07-11 | Universuty Of Rochester | Method of treating symptoms of hormonal variation, including hot flashes |
CA2356829A1 (en) * | 2000-09-22 | 2002-03-22 | Warner-Lambert Company | Method for treating asthma using pregabalin |
DE60210760T2 (en) * | 2001-04-23 | 2006-11-23 | F. Hoffmann-La Roche Ag | USE OF NK-1 RECEPTOR ANTAGONISTS AGAINST BENEFICIAL PROSTATE HYPERPLASIA |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
MXPA05006209A (en) * | 2002-12-13 | 2005-08-19 | Warner Lambert Co | Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders. |
MXPA05006656A (en) * | 2002-12-20 | 2006-02-22 | Dynogen Pharmaceuticals Inc | METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING alpha2. |
US20050043406A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
MX2009006080A (en) * | 2006-12-08 | 2009-07-14 | Xenoport Inc | Use of prodrugs of gaba analogs for treating diseases. |
US8686040B2 (en) * | 2008-03-31 | 2014-04-01 | Rdd Pharma Ltd. | Method for treating anal pruritis and other perianal disorders |
WO2016195723A1 (en) * | 2015-06-03 | 2016-12-08 | Beller Pharmaceuticals LLC | Methods of treatment for conditions mediated by substance p |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL189872B1 (en) * | 1996-07-24 | 2005-10-31 | Warner Lambert Co | Isobutylgabe and its derivatives useful in relieving pains |
-
2000
- 2000-03-10 WO PCT/US2000/006199 patent/WO2000067742A2/en active Application Filing
- 2000-03-10 AU AU37350/00A patent/AU3735000A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000067742A3 (en) | 2001-08-16 |
WO2000067742A2 (en) | 2000-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6883798A (en) | Method of anesthesia | |
AU3867400A (en) | Methods of using bioelastomers | |
AU1345700A (en) | Method of sterilizing females | |
AU4005499A (en) | Method of controlling usage of software components | |
AU8289298A (en) | Phosphocholines of retinoids | |
AU9469198A (en) | New improved formulation for treatment of osteoporosis | |
AU5799098A (en) | Preparation of gabapentin | |
AU2003281327A1 (en) | Antisense modulation of tfg-beta 2 expression | |
AU3789399A (en) | Indolicidin analogs and methods of using same | |
AU5934598A (en) | Manufacture of ascorbyl monophosphates | |
AU7902400A (en) | Method for the preparation of 5-carboxyphthalide | |
AU3735000A (en) | Modulation of substance p by gaba analogs and methods relating thereto | |
PL338679A1 (en) | Method of obtaining l-glutamic acid by fermentation | |
AU3938299A (en) | Method of altering heartbeat | |
AU7876900A (en) | Antisense modulation of fra-1 expression | |
AU4671000A (en) | Method of enhancing insulin action | |
AU4994899A (en) | Modulation of the phospholipase a2 pathway as a therapeutic | |
AU4981199A (en) | Compositions and methods for modulating sexual activity | |
AU5737498A (en) | Method for the preparation of alpha-bromo-lactam derivatives | |
AU7080798A (en) | Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds | |
AU1017199A (en) | Analogs of vitamin e | |
AU1951701A (en) | Methods for modulation of oocyte activation | |
AU1130901A (en) | Method for the preparation of 5-carboxyphthalide | |
AU2668201A (en) | Method for the production of optically active cyanohydrins using r-oxynitrilase | |
AU2382601A (en) | Novel method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |